The hazard
CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-500-10
Theophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-501-10.
- Brand / company
- Brandywine Pharmaceuticals, LLC
- Codes / lots
- Lot: 405617, Expiry: 03/31/2028 | Lot: 405620, Expiry: 03/31/2028.
- Distribution
- Nationwide within U.S
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 4 Nov 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.